Invesco Pharmaceuticals ETF

PJP

Market cap $267M

Pharma's Trump-Pfizer boost sparks momentum, making ETFs PPH, IHE, PJP & XPH attractive for defensive, undervalued growth plays.

Drugmakers have been bracing for levies and sought to get ahead of them with pledges to invest billions more on domestic manufacturing.

Pharmaceutical stocks mostly gained Friday, as traders appeared to shrug off or even cheer President Donald Trump's rollout of a new tariff plan for drugmakers.

Designed to provide broad exposure to the Health Care ETFs category of the market, the Invesco Pharmaceuticals ETF (PJP) is a smart beta exchange traded fund launched on 06/23/2005.

Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the Invesco Pharmaceuticals ETF (PJP) is a passively managed exchange traded fund launched on June 23, 2005.

This article provides a top-down view of the healthcare sector based on valuation, quality and momentum. The healthcare providers and pharmaceuticals/biotechnology subsectors show good value scores. The Invesco Pharmaceuticals ETF has outperformed the pharma industry benchmark XPH and the broader healthcare ETF XLV since 2006.

The Invesco Pharmaceuticals ETF (PJP) was launched on 06/23/2005, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.

Looking for broad exposure to the Healthcare - Pharma segment of the equity market? You should consider the Invesco Pharmaceuticals ETF (PJP), a passively managed exchange traded fund launched on 06/23/2005.

Outlook for pharma sector as Trump pushes for regulatory changes. The impact of tariffs on drugmakers.

President Trump's executive order on drug pricing caused a surprising rally in pharmaceutical stocks, despite initial fears of negative impacts on profit margins. The order lacks enforcement mechanisms, making it difficult to implement, which may explain the positive market reaction. Distributors like McKesson and Cardinal Health were negatively impacted, while manufacturers in the PJP ETF saw gains.